Superworth

Envoy Medical revenue COCH

Sales by quarter and over the last twelve months, from 2022.

Last 12 months, to Jun 30, 2026
$207K
Latest quarter, Q2 FY26
$51K
−35% on a year earlier
Fiscal year 2025
$241K
+7% on the year before

Envoy Medical's revenue was $207K over the twelve months to Jun 30, 2026, down 7% on a year earlier.

In its latest quarter, Q2 FY26, it was $51K, down 35% on the same quarter a year before.

Revenue over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearRevenueChange
FY2025$241K+7%
FY2024$225K−29%
FY2023$316Kn/a
FY2022n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedRevenueOn a year earlierLast 12 months
Q2 FY26$51K−35%$207K
Q1 FY26$39K−15%$234K
Q4 FY25$75K+79%$241K
Q3 FY25$42K−25%$208K
Q2 FY25$78K+15%$222K
Q1 FY25$46K−22%$212K
Q4 FY24$42K−56%$225K
Q3 FY24$56K−30%$278K
Q2 FY24$68K+8%$302K
Q1 FY24$59K−24%$297K
Q4 FY23$95K+375%$316K
Q3 FY23$80K+40%$241K

Against its peers

Companies in Medical - Instruments & Supplies nearest Envoy Medical's size, closest first, today.

CompanyRevenue, 12 monthsGrowth
COCHEnvoy Medical$207K−7% a year
NEPHNephros$20.7M+24% a year
APTAlpha Pro Tech$61.9M+6% a year
KEQUKewaunee Scientific$277.2M+5% a year
PDEXPro DEX$77.5M+16% a year
UTMDUtah Medical Products$36.1M−7% a year
INFUInfuSystem$143.3M+2% a year
EMBCEmbecta$1B−8% a year
Peer median$77.5M

What the revenue tells you

Total sales in the period. On the company page, quarterly bars or the trailing twelve months (TTM), which smooths seasonality.

Growing revenue with shrinking margins is a warning, not a win.

More on Envoy Medical

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.